Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of …
…, S Boyault, A Vincent-Salomon, V Servois… - The lancet …, 2015 - thelancet.com
Background Molecularly targeted agents have been reported to have anti-tumour activity for
patients whose tumours harbour the matching molecular alteration. These results have led …
patients whose tumours harbour the matching molecular alteration. These results have led …
Carotid and vertebral artery dissections: three-dimensional time-of-flight MR angiography and MR imaging versus conventional angiography.
C Levy, JP Laissy, V Raveau, P Amarenco, V Servois… - Radiology, 1994 - pubs.rsna.org
PURPOSE: To compare three-dimensional time-of-flight magnetic resonance (MR) angiography,
MR imaging, and transfemoral four-vessel angiography in diagnosis and follow-up of …
MR imaging, and transfemoral four-vessel angiography in diagnosis and follow-up of …
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma …
…, L Austen, L Moureau-Zabotto, V Servois… - The Lancet …, 2019 - thelancet.com
Background Pathological complete response to preoperative treatment in adults with soft-tissue
sarcoma can be achieved in only a few patients receiving radiotherapy. This phase 2–3 …
sarcoma can be achieved in only a few patients receiving radiotherapy. This phase 2–3 …
Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists
…, S Elles, S Helfre, Y De Rycke, V Servois… - Radiotherapy and …, 2002 - Elsevier
Purpose: Delineation of the gross tumor volume (GTV) and organs at risk constitutes one of
the most important phases of conformal radiotherapy (CRT) procedures. In the absence of a …
the most important phases of conformal radiotherapy (CRT) procedures. In the absence of a …
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
…, A Rampanou, V Servois… - … journal of cancer, 2014 - Wiley Online Library
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have been recently
investigated in several cancer types, but their respective clinical significance remains to be …
investigated in several cancer types, but their respective clinical significance remains to be …
[HTML][HTML] COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
…, S Diakite, A Noret, A Bellesoeur, V Servois… - Breast Cancer …, 2020 - Springer
Background Cancer patients have been reported to be at higher risk of COVID-19 complications
and deaths. We report the characteristics and outcome of patients diagnosed with …
and deaths. We report the characteristics and outcome of patients diagnosed with …
[HTML][HTML] Recommendations for bowel obstruction with peritoneal carcinomatosis
…, P Mariani, C Rebischung, V Servois… - Journal of pain and …, 2014 - Elsevier
This article reports on the clinical practice guidelines developed by a multidisciplinary group
working on the indications and uses of the various available treatment options for relieving …
working on the indications and uses of the various available treatment options for relieving …
[HTML][HTML] Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
…, S Gardrat, RL Barnhill, T Popova, V Servois… - Nature …, 2018 - nature.com
Metastatic uveal melanoma is a deadly disease with no proven standard of care. Here we
present a metastatic uveal melanoma patient with an exceptional high sensitivity to a PD-1 …
present a metastatic uveal melanoma patient with an exceptional high sensitivity to a PD-1 …
Comparative analysis of durable responses on immune checkpoint inhibitors versus other systemic therapies: a pooled analysis of phase III trials
…, M Kamal, C Morel, C Lecerf, V Servois… - JCO Precision …, 2019 - ascopubs.org
PURPOSE Immune checkpoint inhibitors (ICIs) have been demonstrated to improve overall
survival (OS) in several tumor types. Durable responses have been reported with these …
survival (OS) in several tumor types. Durable responses have been reported with these …
Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma
J Madic, S Piperno-Neumann, V Servois… - Clinical Cancer …, 2012 - AACR
Purpose: To develop a molecular tool to detect circulating tumor–derived DNA (ctDNA) in
the plasma from patients with uveal melanoma as a marker of tumor burden and monitor …
the plasma from patients with uveal melanoma as a marker of tumor burden and monitor …